Research News
View articles by month and year
11–17 of 17 articles
-
New Technique May Find Heart Damage Earlier
Research suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional measurement tests.
-
Zometa with Chemo Before Surgery Helps Kill Breast Cancer Cells in Bone Marrow
Research suggests that adding Zometa to chemotherapy given before early-stage breast cancer surgery may destroy breast cancer cells that have traveled to the bone marrow in some women.
-
Adding Taxotere to Standard Chemo Doesn’t Seem to Help Treat Early-Stage Breast Cancer
Taxotere doesn't seem to offer any benefits in treating early-stage breast cancer and also causes more serious side effects.
-
HER2 and Topo II Status Affects Response to Anthracycline Chemo
A new study suggests that anthracycline-based chemotherapy regimens should be used to treat only HER2-positive breast cancers.
-
New Chemo Meds Improve Survival for Women with Advanced-Stage Disease
Newer chemotherapy medicines and regimens, as well as targeted therapy medicines, are helping women with advanced-stage breast cancer live longer.
-
Cancers Resistant to Anthracyclines May Respond to Taxotere-Xeloda Combo
A new study suggests that breast cancer that is resistant to an anthracycline may respond to a combination of two other chemotherapies, Taxotere (chemical name: docetaxel) and Xeloda (chemical name: capecitabine).
-
Taxol Added to Chemo Combination Improved Survival of Women Diagnosed with Early-Stage Breast Cancer
After surgery to treat early-stage breast cancer, women who got Taxol after the FEC (fluorouracil, Ellence, Cytoxan) chemotherapy combination were more likely to be alive and cancer-free 5 years after diagnosis than women who got only FEC.
11–17 of 17 articles
